Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
{{output}}
This article provides new insight on landiolol, an ultra-short acting injectable betablocker, recently approved in Europe, with regard to its pharmacokinetic and pharmacodynamic profile, along with its first experience in Caucasian healthy volunteers and patie... ...
